Amendment One - HHS-NIH-NIAID-BAA2020-1.pdf
PDF 142 KB Posted
- Attached to
- 2020 NIAID Omnibus Broad Agency Announcement
- Solicitation number
- HHS-NIH-NIAID-BAA2020-1
About this file
This Broad Agency Announcement solicits research proposals for five distinct areas related to vaccines, therapeutics, diagnostics and medical countermeasures. Proposals are due on various dates between February 28, 2020 and April 9, 2020 for research managed by the National Institute of Allergy and Infectious Diseases within the Department of Health and Human Services. The funding available totals approximately $27.5 million across multiple anticipated awards.
Research areas include development of a vaccine for acute flaccid myelitis associated with Enterovirus D68, with up to $3 million available. Other areas focus on countermeasures for biothreats and antibiotic resistant bacteria, therapeutics for priority pathogens, and rapid diagnostics. The National Institute of Allergy and Infectious Diseases will manage research on radiation countermeasures, vaccines for biodefense and emerging diseases, and therapeutics. Proposals should further the understanding of infectious diseases and support products to prevent, treat and diagnose conditions.
View the file
Other files
Show all 12
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
HHS-NIH-NIAID-BAA2020-1 Page 1 of 2
Amendment One (1)
NIAID 2020 OMNIBUS BROAD AGENCY ANNOUNCEMENT
HHS-NIH-NIAID-BAA2020-1
AMENDMENT ONE (1)
OFFICE OF ACQUISITIONS
National Institute of Allergy and Infectious Diseases (NIAID)
5601 Fishers Lane, Room 3D38, MSC 9821
Bethesda, MD 20892-9821
Solicitation Number: HHS-NIH-NIAID-BAA2020-1
Date of Solicitation Issuance: January 3, 2020
Date of Amendment One (1) Issuance: January 3, 2020
Number of Pages: 2
Points of Contact: Division of Allergy, Immunology, and
Transplantation (DAIT)
Research Area 001: Development of
Radiation/Nuclear Medical Countermeasures
(MCMs)
Liem Nguyen, Contracting Officer
Email: liem.nguyen@nih.gov
Phone: 240-669-5144
Division of Microbiology and Infectious Diseases
(DMID)
Research Area 002: Advanced Development of
Vaccine Candidates for Acute Flaccid Myelitis
Associated with Enterovirus D68
Research Area 003: Advanced Development of
Vaccine Candidates for Biodefense and Emerging
Infectious Diseases
Research Area 004: Development of Therapeutic
Products for Biodefense, Anti-Microbial Resistant
(AMR) Infections and Emerging Infectious Diseases
Research Area 005: Advanced Development of
Diagnostics for Biothreats and Emerging Infectious mailto:liem.nguyen@nih.gov
HHS-NIH-NIAID-BAA2020-1 Page 2 of 2
Amendment One (1)
Diseases
Primary Contact:
Swee L. Teo, Contracting Officer
Email: teosl@niaid.nih.gov
Phone: 240-669-5173
Secondary Contact:
Brian Madgey, Contracting Officer
Email: brian.madgey@nih.gov
Phone: 240-627-3712
The purpose of Amendment One is to:
1) Reiterate the proposal due dates and time for Research Areas.
2) Provide a cut-off date for questions for Research Area 002.
The responses are offered for information only and do not modify or become part of this solicitation.
Offerors MUST acknowledge receipt of the amendment by Amendment number (s) and date of the amendment. Failure to receive your acknowledgment of this amendment may result in the rejection of your proposal.
Except as provided herein, all terms and conditions of the solicitation remain unchanged and in full force and effect.
1) This BAA contains five (5) distinct Research Areas, each with a specified closing date and time as identified below:
RESEARCH
AREA
NIAID
DIVISION
TITLE RECEIPT DATE
AND TIME
001 DAIT Development of Radiation/Nuclear Medical
Countermeasures (MCMs)
3:00 PM Eastern
Time, 04/09/2020
002 DMID Advanced Development of Vaccine Candidates for Acute Flaccid Myelitis Associated with
Enterovirus D68
3:00 PM Eastern
Time, 02/28/2020
003 DMID Advanced Development of Vaccine Candidates for Biodefense and Emerging Infectious
Diseases
3:00 PM Eastern
Time, 04/09/2020
004 DMID Development of Therapeutic Products for
Biodefense, Anti-Microbial Resistant (AMR)
Infections and Emerging Infectious Diseases
3:00 PM Eastern
Time, 04/09/2020
005 DMID Advanced Development of Diagnostics for
Biothreats and Emerging Infectious Diseases
3:00 PM Eastern
Time, 04/09/2020
2) A cut-off date for questions for Research Area 002 is set at February 14, 2020.
mailto:teosl@niaid.nih.gov mailto:brian.madgey@nih.gov
File details come from the government source that posted it. Updated .